Lv3
260 积分 2026-03-24 加入
Medullary Thyroid Carcinoma
1个月前
已完结
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management
1个月前
已完结
Medullary Thyroid Carcinoma
1个月前
已完结
Genomic alterations in thyroid cancer: biological and clinical insights
1个月前
已完结
Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib
1个月前
已完结
Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence
1个月前
已完结
Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer
1个月前
已完结
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management
1个月前
已完结
Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma Without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort Study
1个月前
已完结
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer
1个月前
已完结
皖公网安备34019202002308